Durch diese Lizenzvereinbarung mit Ablexis erhält Almirall Rechte zur Nutzung der AlivaMab®-Maustechnologie für die Forschung, Entwicklung und Vermarktung von Antikörpern AlivaMab Mouse bietet hochmoderne transgene Mausplattformen, die humane therapeutische Antikörper mit hoher Vielfalt liefern Almirall wird mit AlivaMab Discovery Services … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Spain, Technology
Tagged Ablexis, AlivaMab Discovery Services, AlivaMab Mouse, Almirall, Antikörpermedikament, Antikörpertherapeutika, Biopharmazeutika, dermatologische Erkrankungen, Dr. Thomas Huber, Hautgesundheit, humantherapeutische Antikörper, Justin Mika, Larry Green, Lizenzvereinbarung, schwere Hauterkrankungen
Through this license agreement with Ablexis, Almirall is granted rights to use the AlivaMab® Mouse technology for research, development, and commercialisation of antibodies AlivaMab Mouse offers state-of-the-art transgenic mouse platforms delivering highdiversity human therapeutic antibodies Almirall will partner with AlivaMab … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Spain, Technology
Tagged Ablexis, AlivaMab Discovery Services, AlivaMab Mouse, Almirall, antibody drug, antibody therapeutics, biopharmaceutical, dermatological conditions, Dr. Thomas Huber, human therapeutic antibodies, Justin Mika, Larry Green, licensing agreement, severe skin diseases, skin health
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
